Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: Breast Cancer Res Treat. 2013 Nov 26;143(1):11–18. doi: 10.1007/s10549-013-2758-9

Table 2.

Bivariate analyses for predictors of PFS and OS

Characteristic Median PFS (years) p Median OS (years) p
Age 0.957 0.344
 ≤50 (n = 22) 10.2 11.5
 >50 (n = 29) 8.5 10.3
Menopausal status 0.943 0.499
 Pre (n = 21) 8.5 10.2
 Post (n = 30) 10.2 11.8
Tumor size 0.003 0.001
 ≤2 cm (n = 18) Not reached 25.4
 >2 cm (n = 33) 4.2 7.5
Nodal status 0.036 0.017
 Negative (n = 22) 17.9 17.2
 Positive (n = 29) 4.0 6.7
ER status 0.912 0.374
 Negative (n = 14) 8.1 9.8
 Positive (n = 30) 10.2 12.9
 Unknown (n = 7) 8.5 7.6
Treatment arm 0.064 0.103
 MRM (n = 24) 17.9 14.9
 BCT (n = 27) 4.2 7.6
Chemotherapy use 0.015 0.074
 No (n = 25) 17.9 14.4
 Yes (n = 26) 4.0 7.1
CD44 expression 0.171 0.049
 Negative (n = 29) 4.3 8.6
 Positive (n = 22) 17.9 18.9

Median PFS and OS values are Kaplan–Meier estimates. p values obtained using Log Rank test

Bold values indicate a statiscally significant result (i.e., p< 0.05)